NightHawk Biosciences Inc

## NightHawk Biosciences Inc. NightHawk Biosciences Inc. is a privately held biopharmaceutical company headquartered in Morrisville, North Carolina. With a team of 34 employees, the company has generated $50 million in revenue. NightHawk Biosciences operates as a fully integrated entity, encompassing all stages of drug development from initial discovery to commercialization. The company specializes in developing novel therapies that enhance the body's immune system to combat various diseases. Their focus lies in creating innovative treatments that overcome the limitations often encountered in traditional drug development processes. NightHawk Biosciences aims to deliver high-quality, effective therapies to patients in a timely and efficient manner. NightHawk Biosciences distinguishes itself through its unique integrated ecosystem of subsidiaries. This structure allows for streamlined operations, enhanced control over the development process, and accelerated timelines for bringing new therapies to market. Their commitment to agility and innovation sets them apart in the biopharmaceutical landscape. For more information about NightHawk Biosciences Inc. and their groundbreaking therapies, please visit their website at nighthawkbio.com.